These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 33743684)

  • 1. Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials.
    Mantsios A; Murray M; Karver TS; Davis W; Galai N; Kumar P; Swindells S; Bredeek UF; García RR; Antela A; Gomis SC; Bernáldez MP; Czarnogorski M; Hudson K; Walters N; Kerrigan D
    BMC Health Serv Res; 2021 Mar; 21(1):255. PubMed ID: 33743684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of Implementing Long-Acting Injectable Antiretroviral Therapy to Treat HIV: A Survey of Health Providers from the 13 Countries Participating in the ATLAS-2M Trial.
    Kerrigan D; Murray M; Sanchez Karver T; Mantsios A; Walters N; Hudson K; Kaplan-Lewis E; Pulido F; Bassa AC; Margolis D; Galai N
    AIDS Res Hum Retroviruses; 2021 Mar; 37(3):207-213. PubMed ID: 33323029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting injectable ART to advance health equity: a descriptive analysis of US clinic perspectives on barriers, needed support and programme goals for implementation from applications to the ALAI UP Project.
    Nguyen N; Lane B; Golub SA; Chastain C; Zucker J; King K; Terry M; Burdge J; Carnevale C; Muscarella A; Castor D; Kutner B; Meyers K
    J Int AIDS Soc; 2024 Jul; 27 Suppl 1(Suppl 1):e26282. PubMed ID: 38965977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "A dream come true": Perspectives on long-acting injectable antiretroviral therapy among female sex workers living with HIV from the Dominican Republic and Tanzania.
    Kerrigan D; Sanchez Karver T; Muraleetharan O; Savage V; Mbwambo J; Donastorg Y; Likindikoki S; Perez M; Gomez H; Mantsios A; Murray M; Beckham SW; Davis W; Galai N; Barrington C
    PLoS One; 2020; 15(6):e0234666. PubMed ID: 32530939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying appropriate candidates for long-acting antiretroviral therapy: findings from a survey of health care providers in the ATLAS-2M trial.
    Murray M; Kerrigan D; Hudson KJ; Walters N; Karver TS; Mantsios A; Galai N
    HIV Res Clin Pract; 2020 Aug; 21(4):105-113. PubMed ID: 33048662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Freedom: Patient Experiences with the Transition from Daily Oral to Long-Acting Injectable Antiretroviral Therapy to Treat HIV in the Context of Phase 3 Trials.
    Mantsios A; Murray M; Karver TS; Davis W; Margolis D; Kumar P; Swindells S; Bredeek UF; García Del Toro M; Garcia Gasalla M; Rubio García R; Antela A; Hudson K; Griffith S; Kerrigan D
    AIDS Behav; 2020 Dec; 24(12):3473-3481. PubMed ID: 32410051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives Among Health Care Providers and People with HIV on the Implementation of Long-Acting Injectable Cabotegravir/Rilpivirine for Antiretroviral Therapy in Florida.
    Fisk-Hoffman RJ; Ranger SS; Gracy A; Gracy H; Manavalan P; Widmeyer M; Leeman RF; Cook RL; Canidate S
    AIDS Patient Care STDS; 2024 Jun; 38(6):275-285. PubMed ID: 38686517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain.
    Kerrigan D; Mantsios A; Gorgolas M; Montes ML; Pulido F; Brinson C; deVente J; Richmond GJ; Beckham SW; Hammond P; Margolis D; Murray M
    PLoS One; 2018; 13(1):e0190487. PubMed ID: 29304154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives on long-acting injectable HIV antiretroviral therapy at an alternative care site: a qualitative study of people with HIV experiencing substance use and/or housing instability.
    Fletcher L; Burrowes SAB; Khan GK; Sabin L; Johnson S; Kimmel SD; Ruiz-Mercado G; Pierre C; Drainoni ML
    Harm Reduct J; 2023 Jan; 20(1):4. PubMed ID: 36627679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives of healthcare providers on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation-effectiveness study (CUSTOMIZE).
    Czarnogorski M; Garris CP; Dalessandro M; D'Amico R; Nwafor T; Williams W; Merrill D; Wang Y; Stassek L; Wohlfeiler MB; Sinclair GI; Mena LA; Thedinger B; Flamm JA; Benson P; Spreen WR
    J Int AIDS Soc; 2022 Sep; 25(9):e26003. PubMed ID: 36094142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Acting Injectable Antiretrovirals for HIV Treatment: A Multi-Site Qualitative Study of Clinic-Level Barriers to Implementation in the United States.
    McCrimmon T; Collins LF; Perez-Brumer A; Bazzi AR; Shaffer VA; Kerrigan D; Alcaide ML; Philbin MM
    AIDS Patient Care STDS; 2024 Feb; 38(2):61-69. PubMed ID: 38381949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda.
    Zakumumpa H; Alinaitwe A; Kyomuhendo M; Nakazibwe B
    BMC Infect Dis; 2024 Aug; 24(1):876. PubMed ID: 39198739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding implementation barriers in the national scale-up of differentiated ART delivery in Uganda.
    Zakumumpa H; Rujumba J; Kwiringira J; Katureebe C; Spicer N
    BMC Health Serv Res; 2020 Mar; 20(1):222. PubMed ID: 32183796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient and provider perspectives on implementation barriers and facilitators of an integrated opioid treatment and HIV care intervention.
    Cooke A; Saleem H; Hassan S; Mushi D; Mbwambo J; Lambdin B
    Addict Sci Clin Pract; 2019 Jan; 14(1):3. PubMed ID: 30691511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convenience without disclosure: a formative research study of a proposed integrated methadone and antiretroviral therapy service delivery model in Dar es Salaam, Tanzania.
    Cooke A; Saleem H; Mushi D; Mbwambo J; Hassan S; Lambdin BH
    Addict Sci Clin Pract; 2017 Oct; 12(1):23. PubMed ID: 29041950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives.
    Koester KA; Colasanti JA; McNulty MC; Dance K; Erguera XA; Tsuzuki MD; Johnson MO; Sauceda JA; Montgomery E; Schneider J; Christopoulos KA
    Implement Sci Commun; 2023 Oct; 4(1):128. PubMed ID: 37858272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health provider perspectives on the implementation of the same-day-ART initiation policy in the Gauteng province of South Africa.
    Onoya D; Mokhele I; Sineke T; Mngoma B; Moolla A; Vujovic M; Bor J; Langa J; Fox MP
    Health Res Policy Syst; 2021 Jan; 19(1):2. PubMed ID: 33407574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Patient Decision Aid (i.ARTs) to Facilitate Women's Choice Between Oral and Long-Acting Injectable Antiretroviral Treatment for HIV: Protocols for its Development and Randomized Controlled Pilot Trial.
    Philbin MM; McCrimmon T; Shaffer VA; Kerrigan D; Pereyra M; Cohen MH; Sosanya O; Sheth AN; Adimora AA; Topper EF; Rana A; Tamraz B; Goparaju L; Wilson TE; Alcaide M
    JMIR Res Protoc; 2022 Sep; 11(9):e35646. PubMed ID: 36099004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provider Perspectives on Rapid Treatment Initiation Among People Newly Diagnosed With HIV: A New Message of "Urgency"?
    Uhrig Castonguay BJ; Mancuso N; Hatcher S; Watson S; Okumu E; Abbott R; Golin CE; Mobley V; Samoff E; Swygard H; McNeil CJ; Gay CL
    J Int Assoc Provid AIDS Care; 2024; 23():23259582241269919. PubMed ID: 39234631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Affecting the Implementation of Electronic Antiretroviral Therapy Adherence Monitoring and Associated Interventions for Routine HIV Care in Uganda: Qualitative Study.
    Haberer JE; Garrison L; Tumuhairwe JB; Baijuka R; Tindimwebwa E; Tinkamanyire J; Burns BF; Asiimwe S
    J Med Internet Res; 2020 Sep; 22(9):e18038. PubMed ID: 32687473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.